Facilitated By

San Antonio Medical Foundation

Trending Research

Top viewed research performed by San Antonio Bioscience Organizations


59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
Maj Maddry / LTC Shane

Carmustine (BCNU) is an FDA-approved anti-cancer drug for the treatment of certain types of brain tumors including glioblastoma. Unfortunately, to reach the necessary therapeutic levels in the brain, BCNU needs to be administrated intravenously at a high dosage to compensate for its accumulation in various nonspecific organs, leading to severe adverse side effects, such as bone marrow suppression, pulmonary fibrosis, and hepatic toxicity.

The University of Texas at San Antonio
Ye, JingYong